Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NVIDIA | Jen-Hsun Huang | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 17 Dec 2025 | 39,850,418 | 9,639,142 (1%) | 6% | 0 | Common Stock | |
| NVIDIA | Jen-Hsun Huang | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 17 Dec 2025 | 9,141,011 | 31,421,011 (5%) | 1% | 0 | Common Stock | |
| NVIDIA | Jen-Hsun Huang | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 17 Dec 2025 | 9,141,011 | 0 (0%) | 1% | 0 | Common Stock | |
| LQR House Inc | Yilin Lu | Director, President | Purchase of securities on an exchange or from another person at price $ 0.90 per share. | 17 Dec 2025 | 2,000,000 | 2,000,537 | - | 0.9 | 1,800,000 | Common Stock |
| Kingsway Fin Services Inc | Joseph D. Stilwell | Director, Ten Percent Owner | 17 Dec 2025 | 1,295,411 | 0 | - | - | Stock Option (obligation to sell) | ||
| Kingsway Fin Services Inc | Joseph D. Stilwell | Director, Ten Percent Owner | 17 Dec 2025 | 1,295,411 | 2,254,971 (9%) | 5% | 8.3 | 10,687,141 | Common Stock | |
| Ondas Holdings Inc | Eric A. Brock | Director, Chairman, CEO and President | Other type of transaction at price $ 8.07 per share. | 17 Dec 2025 | 1,153,625 | 1,153,625 | - | 8.1 | 9,309,754 | Common Stock |
| Biocryst Pharma Inc | Charles K. Gayer | President and CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 986,950 | 986,950 | - | - | Emp. Stock Option (Right to Buy) | |
| Cogent Biosciences Inc | Andrews R. Robbins | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 840,000 | 1,025,000 (3%) | 2% | 0 | Common Stock | |
| Carlyle Grp Inc | John C. Redett | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 550,965 | 1,651,081 (0%) | 0% | 0 | Common Stock | |
| HBT Fin Inc | Roger A. Baker | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Dec 2025 | 546,604 | 600 (0%) | 1% | 0 | Common Stock, $0.01 par value | |
| Kingsway Fin Services Inc | Adam J. Patinkin | Director | 17 Dec 2025 | 540,000 | 1,024,000 (4%) | 2% | 8.3 | 4,455,000 | Common Stock | |
| Kingsway Fin Services Inc | Adam J. Patinkin | Director | 17 Dec 2025 | 540,000 | 0 | - | - | Stock Option (Right to Buy) | ||
| Stitch Fix Inc (Class A) | Matthew Baer | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.34 per share. | 17 Dec 2025 | 518,195 | 2,398,961 (4%) | 0% | 5.3 | 2,767,161 | Class A Common Stock |
| Kingsway Fin Services Inc | Adam J. Patinkin | Director | 17 Dec 2025 | 500,000 | 1,524,000 (6%) | 2% | 8.3 | 4,125,000 | Common Stock | |
| Kingsway Fin Services Inc | Adam J. Patinkin | Director | 17 Dec 2025 | 500,000 | 0 | - | - | Stock Option (Right to Buy) | ||
| Kingsway Fin Services Inc | Terence M. Kavanagh | Director | 17 Dec 2025 | 500,000 | 0 | - | - | Stock Option (obligation to sell) | ||
| Kingsway Fin Services Inc | Terence M. Kavanagh | Director | 17 Dec 2025 | 500,000 | 1,987,830 (8%) | 2% | 8.3 | 4,125,000 | Common Stock | |
| Kingsway Fin Services Inc | Gregory P. Hannon | Director | 17 Dec 2025 | 500,000 | 1,987,830 (8%) | 2% | 8.3 | 4,125,000 | Common Stock | |
| Kingsway Fin Services Inc | Gregory P. Hannon | Director | 17 Dec 2025 | 500,000 | 0 | - | - | Stock Option (obligation to sell) | ||
| NVIDIA | Jen-Hsun Huang | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 17 Dec 2025 | 498,131 | 9,141,011 (1%) | 0% | 0 | Common Stock | |
| NVIDIA | Jen-Hsun Huang | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 17 Dec 2025 | 498,131 | 521,735,113 (85%) | 0% | 0 | Common Stock | |
| Biocryst Pharma Inc | Charles K. Gayer | President and CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 471,000 | 889,827 (0%) | 0% | 0 | Common Stock | |
| Cogent Biosciences Inc | Andrews R. Robbins | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.45 per share. | 17 Dec 2025 | 367,497 | 657,503 (2%) | 1% | 39.5 | 14,497,757 | Common Stock |
| Biocryst Pharma Inc | Babar Ghias | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 355,050 | 355,050 | - | - | Emp. Stock Option (Right to Buy) | |
| Navan Inc Ordinary Shares | Benjamin A. Horowitz | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 12.65 per share. | 17 Dec 2025 | 347,600 | 5,922,151 | - | 12.7 | 4,397,140 | Class A Common Stock |
| Stitch Fix Inc (Class A) | Matthew Baer | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.34 per share. | 17 Dec 2025 | 326,717 | 2,072,244 (3%) | 0% | 5.3 | 1,744,669 | Class A Common Stock |
| Cogent Biosciences Inc | Jessica Sachs | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 320,000 | 371,296 (1%) | 1% | 0 | Common Stock | |
| Cogent Biosciences Inc | John Edward Robinson | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 320,000 | 370,000 (1%) | 1% | 0 | Common Stock | |
| Two Harbors Investment Corp | William Greenberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 309,187 | 804,592 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| LoanDepot Inc (Class A) | Anthony Li Hsieh | Director, Executive Chair, CEO & Pres., Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.29 per share. | 17 Dec 2025 | 308,379 | 441,262 (0%) | 0% | 2.3 | 706,990 | Class A Common Stock |
| Stitch Fix Inc (Class A) | Matthew Baer | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 307,413 | 909,938 | - | - | Performance Stock Unit | |
| Cogent Biosciences Inc | John L. Green | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 300,000 | 353,841 (1%) | 1% | 0 | Common Stock | |
| Kingsway Fin Services Inc | Adam J. Patinkin | Director | 17 Dec 2025 | 275,000 | 1,023,000 (4%) | 1% | 8.3 | 2,268,750 | Common Stock | |
| Kingsway Fin Services Inc | Adam J. Patinkin | Director | 17 Dec 2025 | 275,000 | 0 | - | - | Stock Option (Right to Buy) | ||
| Cogent Biosciences Inc | Evan Kearns | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 260,000 | 300,000 (1%) | 0% | 0 | Common Stock | |
| Biocryst Pharma Inc | Alane P. Barnes | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 255,050 | 255,050 | - | - | Emp. Stock Option (Right to Buy) | |
| Kingsway Fin Services Inc | Joshua S. Horowitz | Director | 17 Dec 2025 | 252,500 | 0 | - | - | Stock Option (Right to Buy) | ||
| Kingsway Fin Services Inc | Joshua S. Horowitz | Director | 17 Dec 2025 | 252,500 | 367,500 (1%) | 1% | 8.3 | 2,083,125 | Common Stock | |
| HeartBeam Inc | Mark Strome | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.58 per share. | 17 Dec 2025 | 250,000 | 2,900,000 | - | 3.6 | 895,000 | Common Stock |
| Cogent Biosciences Inc | Andrews R. Robbins | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 245,000 | 245,000 | - | - | Stock Option (Right to Buy) | |
| Navan Inc Ordinary Shares | Benjamin A. Horowitz | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.70 per share. | 17 Dec 2025 | 240,835 | 6,266,946 | - | 14.7 | 3,540,275 | Class A Common Stock |
| Janover Inc | Fei Han | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 226,703 | 226,703 | - | - | Stock Option (Right to buy) | |
| LoanDepot Inc (Class A) | Anthony Li Hsieh | Director, Executive Chair, CEO & Pres., Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.32 per share. | 17 Dec 2025 | 223,488 | 217,774 (0%) | 0% | 2.3 | 519,118 | Class A Common Stock |
| Hycroft Mining Holding Corp (Class A) | Eric Steven Sprott | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.60 per share. | 17 Dec 2025 | 220,000 | 30,606,352 | - | 14.6 | 3,212,000 | Class A common stock |
| Stitch Fix Inc (Class A) | David Aufderhaar | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 219,580 | 307,372 | - | - | Performance Stock Unit | |
| Stitch Fix Inc (Class A) | David Aufderhaar | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.34 per share. | 17 Dec 2025 | 219,580 | 1,437,736 (2%) | 0% | 5.3 | 1,172,557 | Class A Common Stock |
| Stitch Fix Inc (Class A) | Anthony Bacos | Chief Prod/Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 219,580 | 307,372 | - | - | Performance Stock Unit | |
| Stitch Fix Inc (Class A) | Anthony Bacos | Chief Prod/Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.34 per share. | 17 Dec 2025 | 219,580 | 1,244,863 (2%) | 0% | 5.3 | 1,172,557 | Class A Common Stock |
| Kingsway Fin Services Inc | Joseph D. Stilwell | Director, Ten Percent Owner | 17 Dec 2025 | 218,842 | 0 | - | - | Stock Option (obligation to sell) | ||
| Kingsway Fin Services Inc | Joseph D. Stilwell | Director, Ten Percent Owner | 17 Dec 2025 | 218,842 | 371,568 (1%) | 0% | 8.3 | 1,805,447 | Common Stock | |
| LoanDepot Inc (Class A) | Anthony Li Hsieh | Director, Executive Chair, CEO & Pres., Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.28 per share. | 17 Dec 2025 | 217,774 | 0 (0%) | 0% | 2.3 | 496,002 | Class A Common Stock |
| Kingsway Fin Services Inc | Joseph D. Stilwell | Director, Ten Percent Owner | 17 Dec 2025 | 215,477 | 0 | - | - | Stock Option (obligation to sell) | ||
| Kingsway Fin Services Inc | Joseph D. Stilwell | Director, Ten Percent Owner | 17 Dec 2025 | 215,477 | 319,229 (1%) | 0% | 8.2 | 1,777,685 | Common Stock | |
| Janover Inc | Joseph Onorati | Director, CEO & Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 214,659 | 214,659 | - | - | Stock Option (Right to buy) | |
| Cogent Biosciences Inc | Cole Pinnow | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 214,000 | 311,450 (1%) | 0% | 0 | Common Stock | |
| Stitch Fix Inc (Class A) | Matthew Baer | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 210,782 | 1,217,351 | - | - | Performance Stock Unit | |
| Hecla Mining Co. | David C. Sienko | Sr. VP, GC & Secretary | Sale of securities on an exchange or to another person at price $ 19.42 per share. | 17 Dec 2025 | 207,553 | 906,370 (0%) | 0% | 19.4 | 4,030,679 | Common Stock |
| PACS Grp Inc | Jason Murray | Director, Co-Founder, CEO & Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 200,000 | 54,826,199 | - | 0 | Common Stock | |
| Cogent Biosciences Inc | Andrews R. Robbins | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 185,000 | 185,000 (0%) | 0% | 0 | Common Stock | |
| Carlyle Grp Inc | Lindsay P. LoBue | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 183,655 | 660,500 (0%) | 0% | 0 | Common Stock | |
| Janover Inc | Daniel Kang | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 182,616 | 182,616 | - | - | Stock Option (Right to buy) | |
| Arcturus Therapeutics Holdings Inc | Joseph E. Payne | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 175,000 | 175,000 | - | - | Employee Stock Option (right to buy) | |
| PACS Grp Inc | Joshua Jergensen | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 175,000 | 2,684,662 | - | 0 | Common Stock | |
| Post Holdings Inc | William P. Stiritz | Chairman Emeritus | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 170,000 | 0 | - | - | Post Holdings, Inc. Stock Equivalents | |
| Post Holdings Inc | William P. Stiritz | Chairman Emeritus | Sale or transfer of securities back to the company at price $ 101.81 per share. | 17 Dec 2025 | 170,000 | 4,334,667 (6%) | 0% | 101.8 | 17,307,781 | Common Stock |
| Post Holdings Inc | William P. Stiritz | Chairman Emeritus | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 170,000 | 4,504,667 (6%) | 0% | - | Common Stock | |
| Stitch Fix Inc (Class A) | David Aufderhaar | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.34 per share. | 17 Dec 2025 | 161,760 | 1,275,976 (2%) | 0% | 5.3 | 863,798 | Class A Common Stock |
| Sun Communities Inc | Gary A. Shiffman | Director | Sale of securities on an exchange or to another person at price $ 123.53 per share. | 17 Dec 2025 | 156,875 | 0 (0%) | 0% | 123.5 | 19,378,769 | COMMON STOCK, $0.01 PAR VALUE |
| Cogent Biosciences Inc | Jessica Sachs | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.45 per share. | 17 Dec 2025 | 154,716 | 216,580 (0%) | 0% | 39.4 | 6,103,546 | Common Stock |
| PACS Grp Inc | Mark Hancock | Director, Co Fndr; Int CFO; Exec V Chair, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 150,000 | 54,776,199 | - | 0 | Common Stock | |
| Stitch Fix Inc (Class A) | Anthony Bacos | Chief Prod/Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.34 per share. | 17 Dec 2025 | 145,825 | 1,099,038 (1%) | 0% | 5.3 | 778,706 | Class A Common Stock |
| Cogent Biosciences Inc | John L. Green | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.45 per share. | 17 Dec 2025 | 145,007 | 208,834 (0%) | 0% | 39.4 | 5,720,526 | Common Stock |
| NVIDIA | Jen-Hsun Huang | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Dec 2025 | 141,488 | 521,236,982 (85%) | 0% | 0 | Common Stock | |
| Cogent Biosciences Inc | John Edward Robinson | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.45 per share. | 17 Dec 2025 | 139,998 | 230,002 (0%) | 0% | 39.4 | 5,522,921 | Common Stock |
| Janover Inc | Parker White | COO & Chief Investment Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 136,687 | 136,687 | - | - | Stock Option (Right to buy) | |
| Stitch Fix Inc (Class A) | Casey OConnor | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.34 per share. | 17 Dec 2025 | 126,478 | 706,987 (1%) | 0% | 5.3 | 675,393 | Class A Common Stock |
| Stitch Fix Inc (Class A) | Casey OConnor | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 126,478 | 177,047 | - | - | Performance Stock Unit | |
| Cogent Biosciences Inc | Evan Kearns | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.45 per share. | 17 Dec 2025 | 125,602 | 174,398 (0%) | 0% | 39.5 | 4,954,999 | Common Stock |
| Genpact Ltd | Balkrishan Kalra | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 125,130 | 420,376 (0%) | 0% | 0 | Common Shares | |
| Kraft Heinz | Miguel Nuno Da Mata Patricio | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 24.82 per share. | 17 Dec 2025 | 125,000 | 686,817 (0%) | 0% | 24.8 | 3,102,413 | Common Stock |
| Kraft Heinz | Miguel Nuno Da Mata Patricio | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 24.84 per share. | 17 Dec 2025 | 125,000 | 561,817 (0%) | 0% | 24.8 | 3,104,575 | Common Stock |
| Biocryst Pharma Inc | Alane P. Barnes | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 121,700 | 437,426 (0%) | 0% | 0 | Common Stock | |
| Biocryst Pharma Inc | Babar Ghias | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 121,700 | 268,700 (0%) | 0% | 0 | Common Stock | |
| Ventyx Biosciences Inc | Raju S. Mohan | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 116,668 | 2,420,208 | - | 0 | Common Stock | |
| Ventyx Biosciences Inc | Raju S. Mohan | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 116,668 | 0 | - | - | Restricted Stock Units | |
| Lam Research | Timothy M. Archer | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.68 per share. | 17 Dec 2025 | 113,300 | 1,045,709 (0%) | 0% | 17.7 | 2,002,578 | Common Stock |
| Lam Research | Timothy M. Archer | President and CEO | Sale of securities on an exchange or to another person at price $ 163.86 per share. | 17 Dec 2025 | 113,300 | 932,409 (0%) | 0% | 163.9 | 18,565,338 | Common Stock |
| Lam Research | Timothy M. Archer | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 113,300 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| NVIDIA | Colette M. Kress | EVP & Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Dec 2025 | 113,182 | 902,052 (0%) | 0% | 0 | Common | |
| Navan Inc Ordinary Shares | Benjamin A. Horowitz | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.61 per share. | 17 Dec 2025 | 103,960 | 6,026,111 | - | 13.6 | 1,414,896 | Class A Common Stock |
| Two Harbors Investment Corp | William Greenberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 103,948 | 495,405 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| Two Harbors Investment Corp | William Greenberg | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.42 per share. | 17 Dec 2025 | 103,893 | 700,699 (0%) | 0% | 11.4 | 1,186,458 | Common stock, par value $0.01 per share |
| Marqeta Inc (Class A) | Jason Gardner | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.00 per share. | 17 Dec 2025 | 102,439 | 14,320,383 | - | 5.0 | 512,379 | Class A Common Stock |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 38.34 per share. | 17 Dec 2025 | 101,982 | 172,018 | - | 38.3 | 3,910,224 | Class A Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 38.34 per share. | 17 Dec 2025 | 101,594 | 152,406 | - | 38.3 | 3,895,429 | Class A Common Stock |
| Energy Services of America Corp | Marshall T. Reynolds | Director | Sale of securities on an exchange or to another person at price $ 8.37 per share. | 17 Dec 2025 | 100,000 | 1,425,373 | - | 8.4 | 837,000 | Common Stock |
| Navan Inc Ordinary Shares | Anre D. Williams | Director | Purchase of securities on an exchange or from another person at price $ 12.72 per share. | 17 Dec 2025 | 100,000 | 115,024 | - | 12.7 | 1,272,480 | Class A Common Stock |
| Stitch Fix Inc (Class A) | Casey OConnor | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.34 per share. | 17 Dec 2025 | 94,916 | 612,071 (1%) | 0% | 5.3 | 506,851 | Class A Common Stock |
| Cogent Biosciences Inc | Cole Pinnow | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.45 per share. | 17 Dec 2025 | 94,800 | 216,650 (0%) | 0% | 39.5 | 3,739,860 | Common Stock |
| Element Soln Inc | Benjamin H. Gliklich | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Dec 2025 | 93,250 | 1,226,146 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| SoFi Tech Inc | Jeremy Rishel | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 26.64 per share. | 17 Dec 2025 | 91,837 | 794,597 | - | 26.6 | 2,446,538 | Common Stock |
| Sprout Social Inc (Class A) | Aaron Rankin | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.14 per share. | 17 Dec 2025 | 90,661 | 114,969 (0%) | 0% | 11.1 | 1,009,964 | Class A Common Stock |
| Concentra Grp Holdings Parent Inc | William Keith Newton | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Dec 2025 | 89,081 | 89,081 | - | 0 | Common Stock | |
| Concentra Grp Holdings Parent Inc | William Keith Newton | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Dec 2025 | 89,081 | 393,750 | - | 0 | Common Stock | |
| Klaviyo Inc - Ordinary Shares - Series A | Ed Hallen | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 30.37 per share. | 17 Dec 2025 | 82,672 | 525,246 | - | 30.4 | 2,510,749 | Series A Common Stock |
| Xcel Brands Inc | Robert W. D'Loren | Director, CEO and Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.17 per share. | 17 Dec 2025 | 81,466 | 687,297 (3%) | 0% | 1.2 | 94,908 | Common Stock |
| Royalty Pharma PLC (Class A) | George Lloyd | EVP, Investments & CLO | Sale of securities on an exchange or to another person at price $ 38.57 per share. | 17 Dec 2025 | 79,346 | 30,654 | - | 38.6 | 3,060,280 | Class A Ordinary Shares |
| Avidity Biosciences Inc | Eric Mosbrooker | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 72,000 | 127,000 | - | 0 | Common Stock | |
| Avidity Biosciences Inc | Kathleen P. Gallagher | Chief Program Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 72,000 | 122,204 | - | 0 | Common Stock | |
| Mannkind Corp | Michael E. Castagna | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 6.01 per share. | 17 Dec 2025 | 65,804 | 2,504,792 (1%) | 0% | 6.0 | 395,482 | Common Stock, $0.01 Par Value |
| Mannkind Corp | Michael E. Castagna | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.55 per share. | 17 Dec 2025 | 65,804 | 2,570,596 (1%) | 0% | 4.5 | 299,408 | Common Stock, $0.01 Par Value |
| First Industrial Realty Trust Inc | Scott A. Musil | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 17 Dec 2025 | 65,023 | 13,625 (0%) | 0% | 0 | Common Stock | |
| Cogent Biosciences Inc | John L. Green | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Cogent Biosciences Inc | Jessica Sachs | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Cogent Biosciences Inc | John Edward Robinson | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Cogent Biosciences Inc | Cole Pinnow | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Marqeta Inc (Class A) | Jason Gardner | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.00 per share. | 17 Dec 2025 | 62,390 | 14,225,373 | - | 5.0 | 311,956 | Class A Common Stock |
| Phathom Pharma Inc | Steven L. Basta | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 62,038 | 145,288 (0%) | 0% | 0 | Common Stock | |
| Hyperion DeFi Inc | Happy Walters | Director | Purchase of securities on an exchange or from another person at price $ 3.02 per share. | 17 Dec 2025 | 61,930 | 111,930 (0%) | 0% | 3.0 | 187,152 | Common Stock, par value $0.0001 |
| Two Harbors Investment Corp | Nicholas Letica | Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 61,714 | 221,995 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| Elutia Inc (Class A) | Matthew B. Ferguson | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 0.53 per share. | 17 Dec 2025 | 60,000 | 447,110 | - | 0.5 | 31,800 | Class A Common Stock |
| Roivant Sciences Ltd | Mayukh Sukhatme | Director, President & CIO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.68 per share. | 17 Dec 2025 | 59,513 | 18,896,060 | - | 12.7 | 754,625 | Common Shares |
| Roivant Sciences Ltd | Mayukh Sukhatme | Director, President & CIO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 59,513 | 1,304,198 | - | - | Common Shares | |
| Avidity Biosciences Inc | John B. Moriarty | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 56,000 | 103,755 | - | 0 | Common Stock | |
| Two Harbors Investment Corp | Nicholas Letica | Chief Investment Officer | Sale of securities on an exchange or to another person at price $ 11.42 per share. | 17 Dec 2025 | 55,488 | 166,507 (0%) | 0% | 11.4 | 633,723 | Common stock, par value $0.01 per share |
| Cogent Biosciences Inc | Evan Kearns | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
| Arcturus Therapeutics Holdings Inc | Padmanabh Chivukula | Chief Scientific Officer & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 54,000 | 54,000 | - | - | Employee Stock Option (right to buy) | |
| Arcturus Therapeutics Holdings Inc | Lance Kurata | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 54,000 | 54,000 | - | - | Employee Stock Option (right to buy) | |
| Lam Research | Timothy M. Archer | President and CEO | Sale of securities on an exchange or to another person at price $ 163.86 per share. | 17 Dec 2025 | 50,000 | 932,409 (0%) | 0% | 163.9 | 8,193,000 | Common Stock |
| Calumet Specialty Products Partners L.P. - Unit | Bruce Fleming | EVP - MONTANA RENEWABLES | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Dec 2025 | 50,000 | 537,498 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Cogent Biosciences Inc | John L. Green | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 50,000 | 53,841 (0%) | 0% | 0 | Common Stock | |
| Cogent Biosciences Inc | Jessica Sachs | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 50,000 | 51,296 (0%) | 0% | 0 | Common Stock | |
| Cogent Biosciences Inc | John Edward Robinson | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 50,000 | 50,000 (0%) | 0% | 0 | Common Stock | |
| Cogent Biosciences Inc | Cole Pinnow | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 50,000 | 97,450 (0%) | 0% | 0 | Common Stock | |
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | 17 Dec 2025 | 50,000 | 50,000 | - | - | Class A Common Stock | ||
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | 17 Dec 2025 | 50,000 | 25,199,280 | - | - | Class B Common Stock | ||
| Elutia Inc (Class A) | Kevin Rakin | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.52 per share. | 17 Dec 2025 | 50,000 | 322,419 | - | 0.5 | 25,995 | Class A Common Stock |
| Establishment Labs Holdings Inc | Juan Jose Chacon Quiros | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Dec 2025 | 50,000 | 1,078,264 (4%) | 0% | 0 | Common Shares | |
| LifeStance Health Grp Inc | Ann Varanakis | Chief People Officer | Sale of securities on an exchange or to another person at price $ 6.90 per share. | 17 Dec 2025 | 50,000 | 315,610 | - | 6.9 | 345,000 | Common Stock |
| Mannkind Corp | Michael E. Castagna | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 50,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| First Industrial Realty Trust Inc | Scott A. Musil | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 17 Dec 2025 | 49,563 | 62,194 | - | - | LP Units | |
| Esperion Therapeutics Inc | Sheldon L. Koenig | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.67 per share. | 17 Dec 2025 | 48,244 | 1,470,587 (5%) | 0% | 3.7 | 177,200 | Common Stock |
| N-able Inc | Patrick Pulvermueller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 47,493 | 47,493 | - | 0 | Common Stock, par value $0.001 per share | |
| Ventyx Biosciences Inc | Raju S. Mohan | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 7.72 per share. | 17 Dec 2025 | 47,345 | 2,372,863 | - | 7.7 | 365,461 | Common Stock |
| Solaris Energy infra Inc (Class A) | Cynthia M Durrett | Director, CHIEF ADMINISTRATIVE OFFICER | Sale of securities on an exchange or to another person at price $ 44.62 per share. | 17 Dec 2025 | 47,011 | 131,152 (0%) | 0% | 44.6 | 2,097,631 | Class A Common Stock |
| DLH Holdings Corp | Kathryn M. JohnBull | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 46,708 | 609,619 (4%) | 0% | 0 | Common Stock | |
| CBRE Global Real Estate Income Fund | Peter Finnerty | Director | Purchase of securities on an exchange or from another person at price $ 4.32 per share. | 17 Dec 2025 | 46,500 | 46,500 (0%) | 0% | 4.3 | 200,880 | CBRE GLOBAL REAL ESTATE INCOME FUND |
| Arrowhead Pharma Inc | Christopher Anzalone | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 63.55 per share. | 17 Dec 2025 | 46,287 | 3,870,670 (3%) | 0% | 63.6 | 2,941,539 | Common Stock |
| Cencora | James F. Cleary | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 86.09 per share. | 17 Dec 2025 | 45,154 | 180,095 (0%) | 0% | 86.1 | 3,887,308 | Common Stock |
| Cencora | James F. Cleary | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 45,154 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Phreesia Inc | Evan Roberts | President, Provider Solutions | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.71 per share. | 17 Dec 2025 | 44,935 | 835,884 (2%) | 0% | 4.7 | 211,644 | Common Stock |
| Phreesia Inc | Evan Roberts | President, Provider Solutions | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 44,935 | 0 | - | - | Stock Option (Right to Buy) | |
| PACS Grp Inc | Jason Murray | Director, Co-Founder, CEO & Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 41,018 | 54,867,217 | - | 0 | Common Stock | |
| PACS Grp Inc | Mark Hancock | Director, Co Fndr; Int CFO; Exec V Chair, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 41,018 | 54,817,217 | - | 0 | Common Stock | |
| PACS Grp Inc | Joshua Jergensen | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 41,018 | 2,725,680 | - | 0 | Common Stock | |
| Xcel Brands Inc | Robert W. D'Loren | Director, CEO and Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 40,733 | 40,733 | - | - | Warrants | |
| Cogent Biosciences Inc | Evan Kearns | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 40,000 | 40,000 (0%) | 0% | 0 | Common Stock | |
| Avidity Biosciences Inc | Teresa McCarthy | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 39,000 | 136,130 | - | 0 | Common Stock | |
| Toll Brothers Inc | Douglas C. Yearley | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 37,915 | 337,036 (0%) | 0% | 0 | Common Stock | |
| Two Harbors Investment Corp | Rebecca B. Sandberg | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 37,285 | 184,088 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 36,606 | 22,894 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Eric Mosbrooker | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.87 per share. | 17 Dec 2025 | 36,564 | 90,436 | - | 71.9 | 2,627,855 | Common Stock |
| Ellington Fin Inc | JR Herlihy | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 36,417 | 171,870 | - | - | OP LTIP Units | |
| Arrowhead Pharma Inc | Christopher Anzalone | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 64.51 per share. | 17 Dec 2025 | 35,750 | 3,834,920 (3%) | 0% | 64.5 | 2,306,233 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.49 per share. | 17 Dec 2025 | 35,361 | 105,734 (0%) | 0% | 66.5 | 2,351,153 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 75.44 per share. | 17 Dec 2025 | 35,261 | 70,473 (0%) | 0% | 75.4 | 2,660,090 | Common Stock |
| Ventyx Biosciences Inc | John M. Nuss | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 34,930 | 502,156 | - | 0 | Common Stock | |
| Ventyx Biosciences Inc | John M. Nuss | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 34,930 | 0 | - | - | Restricted Stock Units | |
| Klaviyo Inc - Ordinary Shares - Series A | Ed Hallen | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 30.35 per share. | 17 Dec 2025 | 34,878 | 133,624 | - | 30.3 | 1,058,547 | Series A Common Stock |
| Two Harbors Investment Corp | Robert Rush | Chief Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 34,714 | 121,801 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 38.75 per share. | 17 Dec 2025 | 33,939 | 137,000 | - | 38.7 | 1,315,045 | Class A Common Stock |
| Avidity Biosciences Inc | Kathleen P. Gallagher | Chief Program Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.87 per share. | 17 Dec 2025 | 33,336 | 88,868 | - | 71.9 | 2,395,858 | Common Stock |
| Rimini Street Inc | David W. Rowe | CPO,CMO&EVPGlob.Transformation | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 33,333 | 466,290 (0%) | 0% | 0 | Common Stock | |
| Rimini Street Inc | David W. Rowe | CPO,CMO&EVPGlob.Transformation | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 33,333 | 66,667 | - | - | Restricted Stock Units | |
| Rimini Street Inc | Nancy Lyskawa | EVP & Chief Client Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 33,333 | 193,942 (0%) | 0% | 0 | Common Stock | |
| Rimini Street Inc | Nancy Lyskawa | EVP & Chief Client Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 33,333 | 66,667 | - | - | Restricted Stock Units | |
| Rimini Street Inc | Kevin Maddock | EVP,ChiefRecurringRev.Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 33,333 | 186,063 (0%) | 0% | 0 | Common Stock | |
| Rimini Street Inc | Kevin Maddock | EVP,ChiefRecurringRev.Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 33,333 | 66,667 | - | - | Restricted Stock Units | |
| Rimini Street Inc | Steven Hershkowitz | EVP & Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 33,333 | 108,358 (0%) | 0% | 0 | Common Stock | |
| Rimini Street Inc | Steven Hershkowitz | EVP & Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 33,333 | 66,667 | - | - | Restricted Stock Units | |
| Rimini Street Inc | David W. Rowe | CPO,CMO&EVPGlob.Transformation | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 33,333 | 66,667 | - | - | Restricted Stock Units | |
| Rimini Street Inc | David W. Rowe | CPO,CMO&EVPGlob.Transformation | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 33,333 | 466,290 (0%) | 0% | 0 | Common Stock | |
| Rimini Street Inc | Nancy Lyskawa | EVP & Chief Client Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 33,333 | 193,942 (0%) | 0% | 0 | Common Stock | |
| Rimini Street Inc | Nancy Lyskawa | EVP & Chief Client Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 33,333 | 66,667 | - | - | Restricted Stock Units | |
| Rimini Street Inc | Kevin Maddock | EVP,ChiefRecurringRev.Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 33,333 | 66,667 | - | - | Restricted Stock Units | |
| Rimini Street Inc | Kevin Maddock | EVP,ChiefRecurringRev.Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 33,333 | 186,063 (0%) | 0% | 0 | Common Stock | |
| Rimini Street Inc | Steven Hershkowitz | EVP & Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 33,333 | 108,358 (0%) | 0% | 0 | Common Stock | |
| Rimini Street Inc | Steven Hershkowitz | EVP & Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 33,333 | 66,667 | - | - | Restricted Stock Units | |
| HeartBeam Inc | George A. de Urioste | Director | Sale of securities on an exchange or to another person at price $ 2.83 per share. | 17 Dec 2025 | 33,185 | 0 | - | 2.8 | 93,914 | Common Stock |
| Roivant Sciences Ltd | Mayukh Sukhatme | Director, President & CIO | Other type of transaction at price $ 23.09 per share. | 17 Dec 2025 | 32,682 | 18,836,547 | - | 23.1 | 754,627 | Common Shares |
| Marqeta Inc (Class A) | Jason Gardner | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.00 per share. | 17 Dec 2025 | 32,620 | 14,287,763 | - | 5.0 | 163,116 | Class A Common Stock |
| PACS Grp Inc | Michelle Lewis | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 32,500 | 359,091 | - | 0 | Common Stock | |
| Wolfspeed Inc | Eric S. Musser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 31,732 | 31,732 (0%) | 0% | 0 | COMMON STOCK | |
| Wolfspeed Inc | Hong Q. Hou | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 31,732 | 31,732 (0%) | 0% | 0 | COMMON STOCK | |
| Wolfspeed Inc | Paul V. Walsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 31,732 | 31,732 (0%) | 0% | 0 | COMMON STOCK | |
| Wolfspeed Inc | Anthony M. Abate | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 31,732 | 31,732 (0%) | 0% | 0 | COMMON STOCK | |
| Wolfspeed Inc | Mark Edwin Jensen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 31,732 | 31,732 (0%) | 0% | 0 | COMMON STOCK | |
| Wolfspeed Inc | Michael W Bokan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 31,732 | 31,732 (0%) | 0% | 0 | COMMON STOCK | |
| Phathom Pharma Inc | Steven L. Basta | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.36 per share. | 17 Dec 2025 | 31,502 | 113,786 (0%) | 0% | 15.4 | 483,871 | Common Stock |
| Avidity Biosciences Inc | Sarah Boyce | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 31,000 | 336,871 | - | 0 | Common Stock | |
| Royalty Pharma PLC (Class A) | George Lloyd | EVP, Investments & CLO | Sale of securities on an exchange or to another person at price $ 38.50 per share. | 17 Dec 2025 | 30,654 | 0 | - | 38.5 | 1,180,053 | Class A Ordinary Shares |
| Gap Inc | Julie Gruber | Chief Legal&Compliance Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.54 per share. | 17 Dec 2025 | 30,000 | 67,394 (0%) | 0% | 23.5 | 706,200 | Common Stock |
| Gap Inc | Julie Gruber | Chief Legal&Compliance Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 30,000 | 30,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Gap Inc | Julie Gruber | Chief Legal&Compliance Officer | Sale of securities on an exchange or to another person at price $ 28.00 per share. | 17 Dec 2025 | 30,000 | 37,394 (0%) | 0% | 28 | 840,000 | Common Stock |
| Hyperion DeFi Inc | Michael S. Geltzeiler | Director | Purchase of securities on an exchange or from another person at price $ 3.01 per share. | 17 Dec 2025 | 30,000 | 88,015 (0%) | 0% | 3.0 | 90,210 | Common Stock, par value $0.0001 |
| Arista Networks | Kenneth Duda | Director, President and CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.52 per share. | 17 Dec 2025 | 30,000 | 42,976 (0%) | 0% | 3.5 | 105,450 | Common Stock |
| Arista Networks | Kenneth Duda | Director, President and CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 30,000 | 30,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Sensient Tech Corp | Paul Manning | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 29,516 | 29,516 | - | - | Performance Stock Unit | |
| CBL& Associates Properties Inc - Ordinary Shares - New | Stephen D. Lebovitz | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.36 per share. | 17 Dec 2025 | 29,513 | 372,244 | - | 37.4 | 1,102,753 | Common Stock |
| Avidity Biosciences Inc | Sarah Boyce | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Dec 2025 | 29,159 | 291,970 | - | 0 | Common Stock | |
| ON24 Inc | Sharat Sharan | Director, President and Chief Executive, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.70 per share. | 17 Dec 2025 | 28,863 | 3,642,010 | - | 1.7 | 49,067 | Common Stock |
| ON24 Inc | Sharat Sharan | Director, President and Chief Executive, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 28,863 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Pegasystems Inc | Alan Trefler | Director, C.E.O. & Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 57.71 per share. | 17 Dec 2025 | 28,354 | 44,817,300 (56%) | 0% | 57.7 | 1,636,309 | Common stock |
| Marathon Digital Holdings Inc | Frederick G. Thiel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.77 per share. | 17 Dec 2025 | 27,505 | 3,555,489 (45%) | 0% | 10.8 | 296,229 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 27,500 | 107,695 | - | 0 | Common Stock | |
| Two Harbors Investment Corp | Rebecca B. Sandberg | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 11.43 per share. | 17 Dec 2025 | 27,370 | 156,718 (0%) | 0% | 11.4 | 312,787 | Common stock, par value $0.01 per share |
| TXNM Energy Inc | Patricia K. Collawn | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 27,320 | 776,877 (0%) | 0% | 0 | Common Stock | |
| Cencora | James F. Cleary | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 344.14 per share. | 17 Dec 2025 | 26,952 | 153,143 (0%) | 0% | 344.1 | 9,275,396 | Common Stock |
| Roivant Sciences Ltd | Mayukh Sukhatme | Director, President & CIO | Sale of securities on an exchange or to another person at price $ 23.09 per share. | 17 Dec 2025 | 26,831 | 18,869,229 | - | 23.1 | 619,528 | Common Shares |
| Avidity Biosciences Inc | John B. Moriarty | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.87 per share. | 17 Dec 2025 | 26,824 | 76,931 | - | 71.9 | 1,927,841 | Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 38.38 per share. | 17 Dec 2025 | 26,650 | 27,350 | - | 38.4 | 1,022,822 | Class A Common Stock |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 38.38 per share. | 17 Dec 2025 | 26,640 | 27,360 | - | 38.4 | 1,022,430 | Class A Common Stock |
| Compass Inc (Class A) | Scott Wahlers | CFO | Sale of securities on an exchange or to another person at price $ 11.00 per share. | 17 Dec 2025 | 26,600 | 313,625 | - | 11 | 292,600 | Class A Common Stock |
| Elutia Inc (Class A) | Brigid A. Makes | Director | Purchase of securities on an exchange or from another person at price $ 0.52 per share. | 17 Dec 2025 | 25,000 | 27,000 | - | 0.5 | 13,000 | Class A Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 38.73 per share. | 17 Dec 2025 | 24,498 | 127,000 | - | 38.7 | 948,844 | Class A Common Stock |
| HeartBeam Inc | George A. de Urioste | Director | Sale of securities on an exchange or to another person at price $ 3.68 per share. | 17 Dec 2025 | 23,961 | 33,185 | - | 3.7 | 88,176 | Common Stock |
| Pegasystems Inc | Alan Trefler | Director, C.E.O. & Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 58.85 per share. | 17 Dec 2025 | 23,719 | 44,755,654 (56%) | 0% | 58.8 | 1,395,863 | Common stock |
| Two Harbors Investment Corp | Robert Rush | Chief Risk Officer | Sale of securities on an exchange or to another person at price $ 11.42 per share. | 17 Dec 2025 | 23,594 | 98,207 (0%) | 0% | 11.4 | 269,561 | Common stock, par value $0.01 per share |
| General Dynamics | David Paddock | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 23,480 | 0 | - | - | Stock Options | |
| General Dynamics | David Paddock | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 168.56 per share. | 17 Dec 2025 | 23,480 | 57,004 (0%) | 0% | 168.6 | 3,957,789 | Common Stock |
| Avidity Biosciences Inc | Charles Calderaro | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 23,250 | 63,250 | - | 0 | Common Stock | |
| Toll Brothers Inc | Douglas C. Yearley | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 22,789 | 22,789 | - | - | Performance Based Restricted Stock Units | |
| Kingsway Fin Services Inc | Joshua S. Horowitz | Director | 17 Dec 2025 | 22,500 | 32,500 (0%) | 0% | 8.3 | 185,625 | Common Stock | |
| Kingsway Fin Services Inc | Joshua S. Horowitz | Director | 17 Dec 2025 | 22,500 | 0 | - | - | Stock Option (Right to Buy) | ||
| Pegasystems Inc | Alan Trefler | Director, C.E.O. & Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 58.50 per share. | 17 Dec 2025 | 21,281 | 44,779,373 (56%) | 0% | 58.5 | 1,244,939 | Common stock |
| Kingsway Fin Services Inc | Joseph D. Stilwell | Director, Ten Percent Owner | 17 Dec 2025 | 20,270 | 0 | - | - | Stock Option (obligation to sell) | ||
| Kingsway Fin Services Inc | Joseph D. Stilwell | Director, Ten Percent Owner | 17 Dec 2025 | 20,270 | 436,911 (1%) | 0% | 8.3 | 167,228 | Common Stock | |
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 65.42 per share. | 17 Dec 2025 | 20,239 | 12,464 | - | 65.4 | 1,323,985 | Class A Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 20,000 | 0 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.98 per share. | 17 Dec 2025 | 20,000 | 31,206 (0%) | 0% | 2.0 | 39,600 | Common Stock |
| Hallador Energy Co | Charles Wesley | Director | Purchase of securities on an exchange or from another person at price $ 17.83 per share. | 17 Dec 2025 | 20,000 | 267,914 (0%) | 0% | 17.8 | 356,576 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Sale of securities on an exchange or to another person at price $ 7.04 per share. | 17 Dec 2025 | 19,793 | 11,206 (0%) | 0% | 7.0 | 139,303 | Common Stock |
| Sensient Tech Corp | Paul Manning | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 19,677 | 260,940 (0%) | 0% | 0 | Common Stock | |
| PACS Grp Inc | Michelle Lewis | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 19,127 | 378,218 | - | 0 | Common Stock | |
| ON24 Inc | Sharat Sharan | Director, President and Chief Executive, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.82 per share. | 17 Dec 2025 | 19,119 | 3,622,891 | - | 5.8 | 111,366 | Common Stock |
| Ellington Fin Inc | Christopher Smernoff | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 18,209 | 100,366 | - | - | OP LTIP Units | |
| Avidity Biosciences Inc | Teresa McCarthy | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.87 per share. | 17 Dec 2025 | 17,298 | 118,832 | - | 71.9 | 1,243,207 | Common Stock |
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 64.52 per share. | 17 Dec 2025 | 17,297 | 32,703 | - | 64.5 | 1,115,999 | Class A Common Stock |
| Prairie Operating Co | Edward Kovalik | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.69 per share. | 17 Dec 2025 | 16,959 | 2,010,076 (2%) | 0% | 1.7 | 28,661 | Common Stock |
| General Dynamics | David Paddock | Vice President | Sale of securities on an exchange or to another person at price $ 334.88 per share. | 17 Dec 2025 | 16,895 | 36,644 (0%) | 0% | 334.9 | 5,657,730 | Common Stock |
| Magnite Inc | Adam Lee Soroca | CHIEF PRODUCT OFFICER | Sale of securities on an exchange or to another person at price $ 17.00 per share. | 17 Dec 2025 | 16,656 | 326,114 (0%) | 0% | 17 | 283,152 | Common Stock |
| Magnite Inc | Adam Lee Soroca | CHIEF PRODUCT OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 16,656 | 80,001 | - | - | Employee Stock Option (Right to Buy) | |
| Magnite Inc | Adam Lee Soroca | CHIEF PRODUCT OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.92 per share. | 17 Dec 2025 | 16,656 | 342,770 (0%) | 0% | 4.9 | 81,948 | Common Stock |
| Hecla Mining Co. | David C. Sienko | Sr. VP, GC & Secretary | Other type of transaction at price $ 0.00 per share. | 17 Dec 2025 | 16,287 | 16,287 (0%) | 0% | 0 | Common Stock | |
| Enliven Therapeutics Inc | Lori Anne Kunkel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 15,958 | 3,741 | - | - | Stock Option (right to buy) | |
| Enliven Therapeutics Inc | Lori Anne Kunkel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 17 Dec 2025 | 15,958 | 30,712 | - | 1.1 | 17,873 | Common Stock |
| Mannkind Corp | Michael E. Castagna | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 15,804 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Arista Networks | Kenneth Duda | Director, President and CTO | Sale of securities on an exchange or to another person at price $ 122.43 per share. | 17 Dec 2025 | 15,766 | 27,210 (0%) | 0% | 122.4 | 1,930,299 | Common Stock |
| Avidity Biosciences Inc | Sarah Boyce | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.87 per share. | 17 Dec 2025 | 15,742 | 321,129 | - | 71.9 | 1,131,378 | Common Stock |
| Lattice Semiconductor Corp | Pravinchandra Desale | SVP, R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.86 per share. | 17 Dec 2025 | 15,437 | 88,771 (0%) | 0% | 71.9 | 1,109,303 | Common Stock |
| Toll Brothers Inc | Douglas C. Yearley | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 138.67 per share. | 17 Dec 2025 | 15,409 | 321,627 (0%) | 0% | 138.7 | 2,136,766 | Common Stock |
| Airbnb | Aristotle N. Balogh | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 135.00 per share. | 17 Dec 2025 | 15,263 | 165,736 | - | 135 | 2,060,505 | Class A Common Stock |
| Ambarella Inc | Feng-Ming Wang | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Dec 2025 | 15,000 | 768,979 (2%) | 0% | 0 | Ordinary Shares | |
| Prairie Operating Co | Gary C. Hanna | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.69 per share. | 17 Dec 2025 | 14,989 | 2,023,217 (2%) | 0% | 1.7 | 25,331 | Common Stock |
| Castle Biosciences Inc | Kristen M. Oelschlager | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 39.31 per share. | 17 Dec 2025 | 14,888 | 12,323 (0%) | 0% | 39.3 | 585,292 | Common Stock |
| Pegasystems Inc | Alan Trefler | Director, C.E.O. & Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 58.77 per share. | 17 Dec 2025 | 14,593 | 44,802,707 (56%) | 0% | 58.8 | 857,631 | Common stock |
| Kymera Therapeutics Inc | Pamela Esposito | Director | Sale of securities on an exchange or to another person at price $ 81.56 per share. | 17 Dec 2025 | 14,505 | 13,058 | - | 81.6 | 1,182,984 | Common Stock |
| Zeta Global Holdings Corp (Class A) | Imran Khan | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Dec 2025 | 14,028 | 17,120 | - | 0 | Class A Common Stock | |
| Hims & Hers Health Inc (Class A) | Michael Chi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 36.71 per share. | 17 Dec 2025 | 13,750 | 305,161 | - | 36.7 | 504,763 | Class A Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.87 per share. | 17 Dec 2025 | 13,695 | 94,000 | - | 71.9 | 984,260 | Common Stock |
| Viant Tech Inc (Class A) | Lawrence J. Madden | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 11.70 per share. | 17 Dec 2025 | 13,477 | 409,778 | - | 11.7 | 157,735 | Class A Common Stock |
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 65.42 per share. | 17 Dec 2025 | 13,136 | 5,901,781 | - | 65.4 | 859,324 | Class A Common Stock |
| Middlefield Banc Corp | Michael C. Ranttila | EVP/CFO | Grant, award, or other acquisition of securities at price $ 37.00 per share. | 17 Dec 2025 | 12,713 | 22,442 (0%) | 0% | 37 | 470,381 | Common Stock |
| Ventyx Biosciences Inc | John M. Nuss | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 7.72 per share. | 17 Dec 2025 | 12,675 | 489,481 | - | 7.7 | 97,840 | Common Stock |
| Kymera Therapeutics Inc | Pamela Esposito | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.10 per share. | 17 Dec 2025 | 12,563 | 12,563 | - | 49.1 | 616,843 | Common Stock |
| Kymera Therapeutics Inc | Pamela Esposito | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 12,563 | 7,500 | - | - | Stock Option (Right to Buy) | |
| East West Bancorp Inc | Irene H. Oh | Chief Risk Officer | Sale of securities on an exchange or to another person at price $ 115.00 per share. | 17 Dec 2025 | 12,547 | 93,167 (0%) | 0% | 115 | 1,442,905 | Common Stock |
| Elutia Inc (Class A) | David Colpman | Director | Purchase of securities on an exchange or from another person at price $ 0.51 per share. | 17 Dec 2025 | 12,500 | 31,098 | - | 0.5 | 6,375 | Class A Common Stock |
| TXNM Energy Inc | Patricia K. Collawn | Director, EXECUTIVE CHAIR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.71 per share. | 17 Dec 2025 | 12,363 | 764,514 (0%) | 0% | 58.7 | 725,832 | Common Stock |
| Rimini Street Inc | David W. Rowe | CPO,CMO&EVPGlob.Transformation | Sale of securities on an exchange or to another person at price $ 4.02 per share. | 17 Dec 2025 | 12,359 | 453,931 (0%) | 0% | 4.0 | 49,735 | Common Stock |
| Rimini Street Inc | Kevin Maddock | EVP,ChiefRecurringRev.Officer | Sale of securities on an exchange or to another person at price $ 4.02 per share. | 17 Dec 2025 | 12,359 | 173,704 (0%) | 0% | 4.0 | 49,735 | Common Stock |
| Two Harbors Investment Corp | Alecia Hanson | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 12,342 | 56,056 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| Kymera Therapeutics Inc | Pamela Esposito | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 12,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Kymera Therapeutics Inc | Pamela Esposito | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.67 per share. | 17 Dec 2025 | 12,000 | 24,563 | - | 27.7 | 332,040 | Common Stock |
| Airbnb | Aristotle N. Balogh | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 122.41 per share. | 17 Dec 2025 | 11,488 | 180,999 | - | 122.4 | 1,406,246 | Class A Common Stock |
| Airbnb | Aristotle N. Balogh | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 11,488 | 45,953 | - | - | Stock Option | |
| Avidity Biosciences Inc | Eric Mosbrooker | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.87 per share. | 17 Dec 2025 | 11,426 | 79,010 | - | 71.9 | 821,187 | Common Stock |
| Cars.com | Sonia Jain | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.45 per share. | 17 Dec 2025 | 11,400 | 243,642 (0%) | 0% | 13.5 | 153,330 | Common Stock |
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 64.52 per share. | 17 Dec 2025 | 11,228 | 5,914,917 | - | 64.5 | 724,428 | Class A Common Stock |
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | 17 Dec 2025 | 11,195 | 7,963,225 | - | - | Class B Common Stock | ||
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | 17 Dec 2025 | 11,195 | 529,328 (0%) | 0% | 0 | Class A Common Stock | ||
| Apple Hospitality REIT Inc | Nelson G. Knight | President Real Estate & Invest | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Dec 2025 | 11,000 | 919,349 (0%) | 0% | 0 | Common Shares | |
| Marqeta Inc (Class A) | Jason Gardner | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.00 per share. | 17 Dec 2025 | 10,927 | 303,467 | - | 5.0 | 54,655 | Class A Common Stock |
| Two Harbors Investment Corp | Alecia Hanson | Chief Administrative Officer | Sale of securities on an exchange or to another person at price $ 11.41 per share. | 17 Dec 2025 | 10,768 | 45,288 (0%) | 0% | 11.4 | 122,913 | Common stock, par value $0.01 per share |
| Post Holdings Inc | William P. Stiritz | Chairman Emeritus | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 10,703 | 4,345,370 (6%) | 0% | - | Common Stock | |
| Post Holdings Inc | William P. Stiritz | Chairman Emeritus | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 10,703 | 170,000 | - | - | Post Holdings, Inc. Stock Equivalents | |
| Post Holdings Inc | William P. Stiritz | Chairman Emeritus | Sale or transfer of securities back to the company at price $ 101.19 per share. | 17 Dec 2025 | 10,703 | 4,334,667 (6%) | 0% | 101.2 | 1,083,059 | Common Stock |
| Synaptics Inc | Rahul G. Patel | Director, See remarks below | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.84 per share. | 17 Dec 2025 | 10,519 | 120,446 (0%) | 0% | 73.8 | 776,723 | Common Stock |
| Middlefield Banc Corp | Ronald L. Zimmerly | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 37.00 per share. | 17 Dec 2025 | 10,161 | 53,330 (0%) | 0% | 37 | 375,957 | Common Stock |
| Hims & Hers Health Inc (Class A) | Patrick Carroll | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 36.71 per share. | 17 Dec 2025 | 10,021 | 169,940 | - | 36.7 | 367,871 | Class A Common Stock |
| Arcturus Therapeutics Holdings Inc | Joe Roberts | Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 10,000 | 10,000 | - | - | Employee Stock Option (right to buy) | |
| Live Oak Bancshares Inc | James S. Mahan | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 35.97 per share. | 17 Dec 2025 | 10,000 | 3,077,844 (8%) | 0% | 36.0 | 359,699 | Voting Common Stock |
| Rimini Street Inc | Nancy Lyskawa | EVP & Chief Client Officer | Sale of securities on an exchange or to another person at price $ 4.02 per share. | 17 Dec 2025 | 9,927 | 184,015 (0%) | 0% | 4.0 | 39,948 | Common Stock |
| Amphastar Pharma Inc | Rong Zhou | SENIOR EVP, PRODUCTION CENTER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 9,787 | 0 | - | - | Employee Stock Option (right to buy) | |
| Amphastar Pharma Inc | Rong Zhou | SENIOR EVP, PRODUCTION CENTER | Sale of securities on an exchange or to another person at price $ 26.20 per share. | 17 Dec 2025 | 9,787 | 138,043 (0%) | 0% | 26.2 | 256,379 | Common Stock |
| Amphastar Pharma Inc | Rong Zhou | SENIOR EVP, PRODUCTION CENTER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.33 per share. | 17 Dec 2025 | 9,787 | 147,830 (0%) | 0% | 11.3 | 110,887 | Common Stock |
| Avidity Biosciences Inc | Charles Calderaro | Chief Technical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.87 per share. | 17 Dec 2025 | 9,726 | 53,524 | - | 71.9 | 699,008 | Common Stock |
| SR Bancorp Inc | Neil C. Viotto | SVP-Mortgage Lending | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 9,508 | 19,016 | - | 0 | Common Stock | |
| Barings Corporate Investors | Clifford M. Noreen | Director, Chairman of Fund | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 17 Dec 2025 | 9,460 | 312,185 | - | - | Barings Non-Qualified Thrift Plan | |
| TXNM Energy Inc | Joseph D. Tarry | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 9,433 | 58,525 (0%) | 0% | 0 | Common Stock | |
| Amentum Holdings Inc | Sean Thomas Mullen | Chief Growth Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 9,298 | 30,332 | - | - | Common Stock | |
| Amentum Holdings Inc | Sean Thomas Mullen | Chief Growth Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 9,298 | 0 | - | - | Restricted Stock Units | |
| Universal Technical Institute Inc | Jerome A. Grant | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.06 per share. | 17 Dec 2025 | 9,276 | 490,255 (1%) | 0% | 26.1 | 241,733 | Common Stock, $0.0001 par value |
| Lululemon Athletica | Martha A. Morfitt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 9,157 | 9,157 | - | - | Stock Option (right to buy) | |
| Casey`s General Stores Inc | Darren M. Rebelez | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Dec 2025 | 8,825 | 81,015 (0%) | 0% | 0 | Common Stock | |
| QuinStreet Inc | Douglas Valenti | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Dec 2025 | 8,500 | 1,972,724 (3%) | 0% | 0 | Common Stock | |
| Galectin Therapeutics Inc | Khurram Jamil | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. | 17 Dec 2025 | 8,500 | 8,500 (0%) | 0% | 2.5 | 21,250 | Common Stock |
| Galectin Therapeutics Inc | Khurram Jamil | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 7.04 per share. | 17 Dec 2025 | 8,500 | 0 (0%) | 0% | 7.0 | 59,840 | Common Stock |
| Galectin Therapeutics Inc | Khurram Jamil | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 8,500 | 50,000 | - | - | Stock option (right to buy) | |
| Metallus Inc | Michael S. Williams | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 19.04 per share. | 17 Dec 2025 | 8,428 | 722,279 (1%) | 0% | 19.0 | 160,469 | Common Shares |
| Rimini Street Inc | Steven Hershkowitz | EVP & Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 4.02 per share. | 17 Dec 2025 | 8,413 | 99,945 (0%) | 0% | 4.0 | 33,856 | Common Stock |
| Hims & Hers Health Inc (Class A) | Irene Becklund | PAO | Sale of securities on an exchange or to another person at price $ 36.71 per share. | 17 Dec 2025 | 8,411 | 2,126 | - | 36.7 | 308,768 | Class A Common Stock |
| Arista Networks | Kenneth Duda | Director, President and CTO | Sale of securities on an exchange or to another person at price $ 122.43 per share. | 17 Dec 2025 | 8,409 | 1,150,759 (1%) | 0% | 122.4 | 1,029,550 | Common Stock |
| Broadcom | Mark David Brazeal | Chief Legal & Corp Affairs Ofc | Sale of securities on an exchange or to another person at price $ 324.11 per share. | 17 Dec 2025 | 8,354 | 288,053 (0%) | 0% | 324.1 | 2,707,632 | Common Stock, $0.001 par value |
| Avidity Biosciences Inc | Kathleen P. Gallagher | Chief Program Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.87 per share. | 17 Dec 2025 | 8,030 | 80,838 | - | 71.9 | 577,116 | Common Stock |
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 66.34 per share. | 17 Dec 2025 | 7,977 | 4,487 | - | 66.3 | 529,226 | Class A Common Stock |
| Kymera Therapeutics Inc | Pamela Esposito | Director | Sale of securities on an exchange or to another person at price $ 82.34 per share. | 17 Dec 2025 | 7,959 | 5,099 | - | 82.3 | 655,362 | Common Stock |
| Galectin Therapeutics Inc | Joel Lewis | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.86 per share. | 17 Dec 2025 | 7,829 | 840,421 (1%) | 0% | 2.9 | 22,391 | Common Stock |
| Galectin Therapeutics Inc | Joel Lewis | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 7,829 | 32,171 | - | - | Stock option (right to buy) | |
| Galectin Therapeutics Inc | Joel Lewis | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.06 per share. | 17 Dec 2025 | 7,829 | 832,592 (1%) | 0% | 7.1 | 55,241 | Common Stock |
| Innovative Eyewear Inc | Vladimir Galkin | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.38 per share. | 17 Dec 2025 | 7,600 | 925,804 | - | 1.4 | 10,488 | Common Stock, par value $0.00001 |
| Parsons Corp | Carey A. Smith | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.20 per share. | 17 Dec 2025 | 7,541 | 393,003 (0%) | 0% | 60.2 | 453,968 | Common Stock |
| Toll Brothers Inc | Robert Parahus | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 7,483 | 31,557 (0%) | 0% | 0 | Common Stock | |
| Esperion Therapeutics Inc | Benjamin Halladay | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.67 per share. | 17 Dec 2025 | 7,337 | 467,525 (1%) | 0% | 3.7 | 26,905 | Common Stock |
| Toro Co. | Richard M. Olson | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 80.43 per share. | 17 Dec 2025 | 7,122 | 41,434 (0%) | 0% | 80.4 | 572,822 | Common Stock |
| Hims & Hers Health Inc (Class A) | Deborah M. Autor | Director, Chief Policy Officer | Sale of securities on an exchange or to another person at price $ 36.71 per share. | 17 Dec 2025 | 7,054 | 6,175 | - | 36.7 | 258,952 | Class A Common Stock |
| Blue Bird Corp | Razvan Radulescu | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 51.58 per share. | 17 Dec 2025 | 7,006 | 46,180 (0%) | 0% | 51.6 | 361,369 | Common Stock, par value $0.0001 |
| Urban Outfitters Inc | Richard A. Hayne | Director, CEO & Chairman of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 81.59 per share. | 17 Dec 2025 | 6,839 | 17,850,428 (18%) | 0% | 81.6 | 557,994 | Common Shares |
| Lattice Semiconductor Corp | Tracy Ann Feanny | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.86 per share. | 17 Dec 2025 | 6,836 | 71,705 (0%) | 0% | 71.9 | 491,235 | Common Stock |
| Arista Networks | Kenneth Duda | Director, President and CTO | Sale of securities on an exchange or to another person at price $ 123.09 per share. | 17 Dec 2025 | 6,788 | 20,422 (0%) | 0% | 123.1 | 835,524 | Common Stock |
| Marqeta Inc (Class A) | Jason Gardner | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.00 per share. | 17 Dec 2025 | 6,653 | 293,334 | - | 5.0 | 33,266 | Class A Common Stock |
| Esperion Therapeutics Inc | Benjamin O. Looker | General Counsel | Sale of securities on an exchange or to another person at price $ 3.67 per share. | 17 Dec 2025 | 6,517 | 385,905 (1%) | 0% | 3.7 | 23,898 | Common Stock |
| Crescent Energy Co (Class A) | Marcus C. Rowland | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Dec 2025 | 6,500 | 84,535 | - | 0 | Class A Common Stock | |
| Galectin Therapeutics Inc | Khurram Jamil | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 7.04 per share. | 17 Dec 2025 | 6,463 | 0 (0%) | 0% | 7.0 | 45,500 | Common Stock |
| Galectin Therapeutics Inc | Khurram Jamil | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.20 per share. | 17 Dec 2025 | 6,463 | 6,463 (0%) | 0% | 2.2 | 14,219 | Common Stock |
| Galectin Therapeutics Inc | Khurram Jamil | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 6,463 | 102,037 | - | - | Stock option (right to buy) | |
| DuPont de Nemours | Edward D. Breen | Director, Executive Chair | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.61 per share. | 17 Dec 2025 | 6,061 | 325,622 (0%) | 0% | 40.6 | 246,107 | Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 38.70 per share. | 17 Dec 2025 | 6,000 | 6,000 | - | 38.7 | 232,180 | Class A Common Stock |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 38.71 per share. | 17 Dec 2025 | 6,000 | 6,000 | - | 38.7 | 232,232 | Class A Common Stock |
| Urban Outfitters Inc | Margaret A. Hayne | Director, Co-President & CCO | Sale of securities on an exchange or to another person at price $ 81.59 per share. | 17 Dec 2025 | 5,984 | 2,284,743 (2%) | 0% | 81.6 | 488,235 | Common Shares |
| Urban Outfitters Inc | Richard A. Hayne | Director, CEO & Chairman of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 81.59 per share. | 17 Dec 2025 | 5,984 | 2,284,743 (2%) | 0% | 81.6 | 488,235 | Common Shares |
| Toll Brothers Inc | Robert Parahus | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 5,829 | 5,829 | - | - | Performance Based Restricted Stock Units | |
| Astrazeneca PLC (ADR) | Philip A J Broadley | Non-Executive Director,Senior Independent Director | 17 Dec 2025 | 5,735 | 8,025 (0%) | 0% | 0 | Ords 0.25p | ||
| Astrazeneca PLC (ADR) | Philip A J Broadley | Non-Executive Director,Senior Independent Director | 17 Dec 2025 | 5,735 | 2,290 (0%) | 0% | 0 | Ords 0.25p | ||
| SR Bancorp Inc | Christopher J. Pribula | Director, President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 5,705 | 55,638 | - | 0 | Common Stock | |
| Metallus Inc | Michael S. Williams | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 19.07 per share. | 17 Dec 2025 | 5,609 | 716,670 (1%) | 0% | 19.1 | 106,964 | Common Shares |
| FormFactor Inc | Michael D. Slessor | Director, CEO | Sale of securities on an exchange or to another person at price $ 56.19 per share. | 17 Dec 2025 | 5,606 | 527,664 (0%) | 0% | 56.2 | 315,001 | Common Stock |
| Braze Inc (Class A) | Pankaj Malik | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 35.76 per share. | 17 Dec 2025 | 5,540 | 53,572 | - | 35.8 | 198,110 | Class A Common Stock |
| Broadcom | Mark David Brazeal | Chief Legal & Corp Affairs Ofc | Sale of securities on an exchange or to another person at price $ 323.08 per share. | 17 Dec 2025 | 5,473 | 296,407 (0%) | 0% | 323.1 | 1,768,217 | Common Stock, $0.001 par value |
| Innovative Eyewear Inc | Vladimir Galkin | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.38 per share. | 17 Dec 2025 | 5,366 | 933,404 | - | 1.4 | 7,405 | Common Stock, par value $0.00001 |
| Jack Henry & Associates | Mimi L. Carsley | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 5,350 | 5,350 | - | - | Restricted Stock Units | |
| LendingClub Corp | Annie Armstrong | Chief Risk Officer | Sale of securities on an exchange or to another person at price $ 18.83 per share. | 17 Dec 2025 | 5,333 | 368,359 (0%) | 0% | 18.8 | 100,435 | Common Stock |
| Lattice Semiconductor Corp | Esam Elashmawi | SVP Mktg & Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.86 per share. | 17 Dec 2025 | 5,293 | 323,440 (0%) | 0% | 71.9 | 380,355 | Common Stock |
| Arista Networks | Kenneth Duda | Director, President and CTO | Sale of securities on an exchange or to another person at price $ 122.43 per share. | 17 Dec 2025 | 5,255 | 537,145 (0%) | 0% | 122.4 | 643,392 | Common Stock |
| BV Fin Inc | Rose M. Searcy | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.65 per share. | 17 Dec 2025 | 5,230 | 6,730 | - | 5.7 | 29,550 | Common Stock |
| BV Fin Inc | Rose M. Searcy | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 5,230 | 2,424 | - | - | Stock Options | |
| Middlefield Banc Corp | Sarah A. Winters | EVP/CHRO | Grant, award, or other acquisition of securities at price $ 37.00 per share. | 17 Dec 2025 | 5,204 | 5,809 (0%) | 0% | 37 | 192,548 | Common Stock |
| Middlefield Banc Corp | Michael L. Cheravitch | EVP-Chief Banking Officer | Grant, award, or other acquisition of securities at price $ 37.00 per share. | 17 Dec 2025 | 5,204 | 5,809 (0%) | 0% | 37 | 192,548 | Common Stock |
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 66.34 per share. | 17 Dec 2025 | 5,178 | 5,896,603 | - | 66.3 | 343,529 | Class A Common Stock |
| Sensient Tech Corp | Michael C. Geraghty | President, Color Group | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 5,126 | 5,126 | - | - | Performance Stock Unit | |
| Phreesia Inc | Evan Roberts | President, Provider Solutions | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 5,065 | 17,690 | - | - | Stock Option (Right to Buy) | |
| Phreesia Inc | Evan Roberts | President, Provider Solutions | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.03 per share. | 17 Dec 2025 | 5,065 | 840,949 (2%) | 0% | 8.0 | 40,672 | Common Stock |
| Horace Mann Educators Corp | Bret A. Conklin | Executive Vice President | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Dec 2025 | 5,036 | 54,319 (0%) | 0% | 0 | Common Stock | |
| Analog Devices | Martin Cotter | SVP, Vertical Business Units | Sale of securities on an exchange or to another person at price $ 271.19 per share. | 17 Dec 2025 | 5,000 | 59,663 (0%) | 0% | 271.2 | 1,355,951 | Comm Stock-$.16-2/3 value |
| RenovoRx Inc | Shaun R. Bagai | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.85 per share. | 17 Dec 2025 | 5,000 | 335,040 | - | 0.9 | 4,262 | Common Stock |
| UGI Corp | Joseph L. Hartz | President of Subsidiary | Sale of securities on an exchange or to another person at price $ 38.45 per share. | 17 Dec 2025 | 5,000 | 33,492 (0%) | 0% | 38.4 | 192,237 | UGI Common Stock |
| UGI Corp | Joseph L. Hartz | President of Subsidiary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.76 per share. | 17 Dec 2025 | 5,000 | 38,492 (0%) | 0% | 33.8 | 168,800 | UGI Common Stock |
| UGI Corp | Joseph L. Hartz | President of Subsidiary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 5,000 | 0 | - | - | Options (Right to Buy) | |
| Honeywell | Billal M. Hammoud | President & CEO, BA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 4,993 | 4,993 | - | - | Restricted Stock Units | |
| Ambarella Inc | Feng-Ming Wang | Director, CEO | Sale of securities on an exchange or to another person at price $ 71.82 per share. | 17 Dec 2025 | 4,950 | 783,979 (2%) | 0% | 71.8 | 355,509 | Ordinary Shares |
| CBL& Associates Properties Inc - Ordinary Shares - New | Michael I. Lebovitz | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.36 per share. | 17 Dec 2025 | 4,919 | 51,575 | - | 37.4 | 183,798 | Common Stock |
| CBL& Associates Properties Inc - Ordinary Shares - New | Jeffery V. Curry | Chief Legal Officer & Sec. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.36 per share. | 17 Dec 2025 | 4,919 | 92,683 | - | 37.4 | 183,798 | Common Stock |
| CBL& Associates Properties Inc - Ordinary Shares - New | Katie A. Reinsmidt | EVP - Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.36 per share. | 17 Dec 2025 | 4,919 | 97,101 | - | 37.4 | 183,798 | Common Stock |
| Urban Outfitters Inc | Richard A. Hayne | Director, CEO & Chairman of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 82.54 per share. | 17 Dec 2025 | 4,893 | 17,860,181 (18%) | 0% | 82.5 | 403,878 | Common Shares |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Sale of securities on an exchange or to another person at price $ 7.04 per share. | 17 Dec 2025 | 4,706 | 6,500 (0%) | 0% | 7.0 | 33,121 | Common Stock |
| Middlefield Banc Corp | Ronald L. Zimmerly | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 37.00 per share. | 17 Dec 2025 | 4,653 | 43,169 (0%) | 0% | 37 | 172,161 | Common Stock |
| Arista Networks | Kenneth Duda | Director, President and CTO | Sale of securities on an exchange or to another person at price $ 124.32 per share. | 17 Dec 2025 | 4,553 | 15,869 (0%) | 0% | 124.3 | 566,030 | Common Stock |
| Weyerhaeuser | Sara Grootwassink Lewis | Director | Purchase of securities on an exchange or from another person at price $ 23.61 per share. | 17 Dec 2025 | 4,500 | 25,978 (0%) | 0% | 23.6 | 106,226 | Common |
| Galectin Therapeutics Inc | Khurram Jamil | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 7.04 per share. | 17 Dec 2025 | 4,479 | 0 (0%) | 0% | 7.0 | 31,532 | Common Stock |
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 137.95 per share. | 17 Dec 2025 | 4,422 | 520,942 (0%) | 0% | 138.0 | 610,029 | Class A Common Stock |
| Sensient Tech Corp | Tobin Tornehl | VP and Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 4,350 | 4,350 | - | - | Performance Stock Unit | |
| TransUnion | Tiffani Chambers | EVP, Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 86.00 per share. | 17 Dec 2025 | 4,318 | 50,427 (0%) | 0% | 86 | 371,348 | Common Stock |
| Palvella Therapeutics Inc | Kathleen Goin | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 96.47 per share. | 17 Dec 2025 | 4,302 | 0 | - | 96.5 | 415,023 | Common Stock |
| Urban Outfitters Inc | Margaret A. Hayne | Director, Co-President & CCO | Sale of securities on an exchange or to another person at price $ 82.54 per share. | 17 Dec 2025 | 4,282 | 2,293,276 (2%) | 0% | 82.5 | 353,445 | Common Shares |
| Urban Outfitters Inc | Richard A. Hayne | Director, CEO & Chairman of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 82.54 per share. | 17 Dec 2025 | 4,282 | 2,293,276 (2%) | 0% | 82.5 | 353,445 | Common Shares |
| TXNM Energy Inc | Joseph D. Tarry | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.71 per share. | 17 Dec 2025 | 4,269 | 54,256 (0%) | 0% | 58.7 | 250,633 | Common Stock |
| General Dynamics | David Paddock | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 223.93 per share. | 17 Dec 2025 | 4,260 | 33,524 (0%) | 0% | 223.9 | 953,942 | Common Stock |
| General Dynamics | David Paddock | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 4,260 | 0 | - | - | Stock Options | |
| Sensient Tech Corp | John J. Manning | SVP, GC & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 4,195 | 4,195 | - | - | Performance Stock Unit |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.